An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multiple Myeloma

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 26, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

July 31, 2028

Conditions
Relapsed/Refractory Multiple Myeloma
Interventions
DRUG

BCD-248

subcutaneously

Trial Locations (20)

Unknown

NOT_YET_RECRUITING

"SBHI of the Kaliningrad region Central City Clinical Hospital", Kaliningrad

NOT_YET_RECRUITING

"SAHI Republican Clinical Oncology Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor M.Z. Sigala", Kazan'

NOT_YET_RECRUITING

"FSBI of science Kirov research Institute of Hematology and blood transfusion of the Federal medical and biological Agency", Kirov

RECRUITING

"Regional Government-Owned Publicly Funded Healthcare Institution Regional Clinical Hospital", Krasnoyarsk

RECRUITING

"Branch of the limited liability company Hadassah Medical LTD", Moscow

RECRUITING

City Clinical Hospital №52 of the Department of Health of the City of Moscow, Moscow

NOT_YET_RECRUITING

"FSBI National Medical Research Center of Oncology named after N. N. Blokhin of the Ministry of Health of the Russian Federation", Moscow

RECRUITING

"JSC Medsi Group of Companies", Moscow

NOT_YET_RECRUITING

SBI of health care of the city of Moscow city clinical hospital named after S. P. Botkin of the Department of health of the City of Moscow, Moscow

NOT_YET_RECRUITING

"State budgetary healthcare Institution of the Moscow Region Moscow Regional Research Clinical Institute named after M. F. Vladimirsky", Moscow

NOT_YET_RECRUITING

"Federal State Budgetary Institution National Medical Research Center for Radiology of the Ministry of Health of the Russian Federation", Obninsk

NOT_YET_RECRUITING

"SBHI of the Republic of Karelia Republican Hospital named after V.A. Baranov", Petrozavodsk

RECRUITING

"FSBI Almazov National Medical Research Centre of the Ministry of Health of the Russian Federation", Saint Petersburg

NOT_YET_RECRUITING

"FSBEI of Higher Education Samara State Medical University of the Ministry of Health of the Russian Federation", Samara

RECRUITING

"FSBEI HE Saratov State Medical University named after V.I. Razumovsky of the Ministry of Health of Russia", Saratov

NOT_YET_RECRUITING

"Private healthcare institution Clinical hospital RZD-Medicine of the city of Smolensk", Smolensk

NOT_YET_RECRUITING

"State Budgetary Healthcare Institution Oncological Dispensary No.2 of the Ministry of Health of the Krasnodar Region", Sochi

RECRUITING

"Public institution Komi Republican cancer clinic", Syktyvkar

NOT_YET_RECRUITING

"FSBEI of Higher Education Bashkir State Medical University of the Ministry of Health of the Russian Federation", Ufa

NOT_YET_RECRUITING

"State budgetary healthcare institution of the Sverdlovsk region Sverdlovsk regional clinical hospital №1", Yekaterinburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biocad

INDUSTRY

NCT06668792 - An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multiple Myeloma | Biotech Hunter | Biotech Hunter